Alert

Clinical Trial Details Page

Halo-109-301

Objective

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma

IRB Protocol Number
NCT02715804

Clinical Trial Categories

  • Gastrointestinal Cancer
Contact
Nancy Burns at 919-784-7209
or Nancy.Burns2@unchealth.unc.edu
How to Participate

View eligibility criteria and additional study information.

Related Locations

Top